Ken Griffin Pulse Biosciences, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 9,800 shares of PLSE stock, worth $142,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,800

Previous 14,000 30.0%

Holding current value

$142,688

Previous $121,000 9.92%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.8 - $11.02 $392,979 - $555,209	50,382 Added 1361.68%	54,082 $471,000
Q4 2023 Feb 14, 2024	BUY	$3.85 - $12.84 $12,585 - $41,973	3,269 Added 758.47%	3,700 $45,000
Q3 2023 Nov 14, 2023	BUY	$4.03 - $8.73 $1,736 - $3,762	431 New	431 $1,000
Q1 2023 May 15, 2023	SELL	$2.48 - $3.88 $60,888 - $95,261	-24,552 Reduced 99.95%	13 $0
Q4 2022 Feb 14, 2023	BUY	$1.73 - $2.89 $42,497 - $70,992	24,565 New	24,565 $68,000
Q2 2022 Aug 15, 2022	BUY	$1.48 - $4.28 $93,833 - $271,356	63,401 New	63,401 $97,000
Q2 2020 Aug 14, 2020	SELL	$6.23 - $13.09 $78,217 - $164,344	-12,555 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.23 - $15.2 $100,750 - $292,812	-19,264 Reduced 60.54%	12,555 $90,000
Q1 2018 May 11, 2018	SELL	$12.67 - $24.69 $3.88 Million - $7.56 Million	-306,087 Reduced 90.58%	31,819 $431,000
Q4 2017 Feb 09, 2018	BUY	$18.81 - $30.33 $6.36 Million - $10.2 Million	337,906	337,906 $7.98 Million

Others Institutions Holding PLSE

# of Institutions

Shares Held

4.8M

Call Options Held

138K

Put Options Held

96.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account